Abstract
Due to urbanization and economic development, the metabolic syndrome has become prevalent in Asia and will be an important risk factor for cardiovascular diseases. Overeating and lack of physical activity lead to central obesity, the metabolic syndrome and cardiovascular diseases. Excess fat increases fatty acids in the blood, and also causes local and widespread inflammation. This inflammation is harmful to blood vessels and leads to endothelial dysfunction, high blood pressure and atherosclerosis. Lifestyle modification is the key to preventing the metabolic syndrome. Metformin, acarbose and glitazones may help to prevent the development of diabetes. Orlistat has a limited role for treating obesity, but there are new drugs for obesity in the pipeline.
Original language | English |
---|---|
Title of host publication | Life Sciences of the Asia Pacific Region |
Publisher | Nova Science Publishers Inc |
Pages | 157-174 |
Number of pages | 18 |
ISBN (Print) | 9781614701170 |
Publication status | Published - 1 Dec 2012 |
Keywords
- Asians
- Cardiovascular disease
- Diabetes
- Lipids
- Metabolic syndrome
- Obesity
ASJC Scopus subject areas
- General Social Sciences